Capstone Holding Corp.’s (NASDAQ:CAPS) Quiet Period Will End Tomorrow

Capstone’s (NASDAQ:CAPS) quiet period is set to expire on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During Capstone’s quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Capstone Stock Down 1.7 %

Shares of NASDAQ:CAPS opened at $2.38 on Monday. Capstone has a 12-month low of $1.65 and a 12-month high of $16.18.

Capstone Company Profile

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism.